Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.13 USD | -2.11% | +0.12% | +56.58% |
05-10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
05-09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.6B | - | - | - | - | - | |
54.64B | - | |||||
39.92B | ||||||
38.82B | ||||||
26.86B | ||||||
26.22B |